Finance

Lists
CPH:TSE
Cipher Pharmaceuticals Inc
CADΒ 13,07
-0,98%
(-0,13) 1D
3 Nov., 16:00:00 GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CPH...
Open
CADΒ 13,17
High
CADΒ 13,17
Low
CADΒ 12,97
Mkt. cap
329,77Β m
Avg. vol.
19,83Β k
Volume
9,58Β k
P/E ratio
8,32
52-wk high
CADΒ 20,56
52-wk low
CADΒ 12,48
EPS
CADΒ 1,57
Beta
-0,18
Shares outstanding
25,42Β m
No. of employees
43
Open
CADΒ 13,17
High
CADΒ 13,17
Low
CADΒ 12,97
Mkt. cap
329,77Β m
Avg. vol.
19,83Β k
Volume
9,58Β k
P/E ratio
8,32
52-wk high
CADΒ 20,56
52-wk low
CADΒ 12,48
EPS
CADΒ 1,57
Beta
-0,18
Shares outstanding
25,42Β m
No. of employees
43
News stories
From web sources and news partners
About Cipher Pharmaceuticals Inc
CEO-
Employees43
Founded2000
HeadquartersMississauga, Ontario, Kanada
SectorPharmaceutical industry
Industry-
Websitecipherpharma.com
Next call oor 9 dae
Vr. 13 Nov., 15:30
Fiscal period
Q3 2026
- / -
Revenue / Est. (CAD)
- / 18,20Β m
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
12,83Β m
12,22Β m
12,50Β m
12,07Β m
Cost of goods sold
2,35Β m
2,30Β m
2,21Β m
2,37Β m
Cost of revenue
2,35Β m
2,30Β m
2,21Β m
2,37Β m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,71Β m
3,68Β m
2,90Β m
3,18Β m
Operating expense
5,51Β m
5,49Β m
4,70Β m
4,96Β m
Total operating expenses
7,86Β m
7,79Β m
6,91Β m
7,33Β m
Operating income
4,97Β m
4,43Β m
5,60Β m
4,73Β m
Other non operating income
-
-
-
-
EBT including unusual items
4,26Β m
4,61Β m
4,95Β m
3,64Β m
EBT excluding unusual items
4,13Β m
4,84Β m
4,89Β m
3,90Β m
Income tax expense
-1,24Β m
-8,70Β m
-1,21Β m
-369,00Β k
Effective tax rate
-29,19%
-188,55%
-24,53%
-10,13%
Other operating expenses
-
-
-
-
Net income
5,50Β m
13,31Β m
6,16Β m
4,01Β m
Net profit margin
42,87%
108,95%
49,28%
33,26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
15,00Β k
Interest expense
-241,00Β k
-109,00Β k
-51,00Β k
-
Net interest expenses
-241,00Β k
-109,00Β k
-51,00Β k
15,00Β k
Depreciation and amortization charges
1,80Β m
1,81Β m
1,81Β m
1,78Β m
EBITDA
6,77Β m
5,95Β m
7,32Β m
6,44Β m
Gain or loss from assets sale
-
-130,00Β k
-57,00Β k
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme